Pharos iBio Co., Ltd. (KOSDAQ:388870)
5,310.00
+220.00 (4.32%)
At close: Aug 24, 2026
-5.01% (1Y)
| Market Cap | 65.89B -11.0% |
| Revenue (ttm) | n/a |
| Net Income | -9.49B |
| EPS | -732.86 |
| Shares Out | 12.95M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 34,843 |
| Open | 5,150.00 |
| Previous Close | 5,090.00 |
| Day's Range | 5,150.00 - 5,390.00 |
| 52-Week Range | 3,710.00 - 12,120.00 |
| Beta | -0.35 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Nov 11, 2026 |